Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release.

Encinas-Basurto, David; Konhilas, John P; Polt, Robin; Hay, Meredith; Mansour, Heidi M

Encinas-Basurto, David; Konhilas, John P; Polt, Robin; Hay, Meredith; Mansour, Heidi M.

Afiliación

Encinas-Basurto D; Skaggs Pharmaceutical Sciences Center, College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA.
Konhilas JP; Department of Physiology and Sarver Heart Center, The University of Arizona, Tucson, AZ 85721, USA.
Polt R; Department of Chemistry & Biochemistry, The University of Arizona, Tucson, AZ 85721, USA.
Hay M; BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA.
Mansour HM; Department of Physiology and Evelyn F. McKnight, Brain Institute, The University of Arizona, Tucson, AZ 85721, USA.

Pharmaceutics ; 14(3)2022 Mar 08.

Article en En | MEDLINE | ID: mdl-35335963

Palabras clave

PLGA diblock copolymer; PNA5 glycopeptide; angiotensin; biocompatible; biodegradable; cardiovascular; double emulsion solvent evaporation; ester and acid-end capped; mas receptor; neurodegenerative diseases

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google